WL, It has some good questions in there, needs a fair bit of polish. Could you please use a polished version of these paragraph for my questions.
++++Dr Esra OGRU was recntly quoted saying "We are working alongside 42 Pharmaceutical Companies" in an investment newsletter. This has not previously been announced to shareholders. Is the quote correct and if so, how many companies are we in meaningful commercial discussions with. How many drugs/products have we successfully formulated. How many drugs/products have we identified as having commercial viability.++++++
++++++ On 9.9.09 Company announced it was to" Commence Phase 2/3 Trials on Diclofenac " In the second last paragraph of that announcement Dr Paul Gavan said "progress into phase 2 or 3 trial." Which is statement iscorrect , the heading or last paragraph. Has the trial now commenced and which phase is it actually in. Will this be the last trial enabling after successful completion a FDA submission seeking approval to market the TPM/Diclofenac."
++++++++Given that POH is focusing on generic drugs that have approvals in place. Is it quicker time to approval ,for TPM/generic drug, than a new drug. Recently ACL announcemed orally delivered Fondaparinux is expected to take only two years to market.+++++
Sorry Weighlifter if I have too many questions, but have written them for you. I would really like to see a well constructed quetion regarding Fat Burner Cream.
I am happy to give it some thought and post a paragraph for inclusion unless another poster can come up with a good one. Remember if the fat burner is successful it will be on market in 2010. And be our biggest seller by far.
Anyone that crafts a great question to send in,can sit at my table with Playez and the strippers for dollar party.
PoS.
- Forums
- ASX - By Stock
- AVE
- working draft
working draft, page-2
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 44263580 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.002 |
16 | 22966742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 44170247 | 21 |
0.004 | 34681763 | 17 |
0.005 | 16900219 | 10 |
0.006 | 9723435 | 9 |
0.007 | 13229103 | 6 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
Day chart unavailable